Abstract
The past year has seen the reassessment of several antiprotozoal agents and anthelmintics, particularly in the immunocompromised patient with intestinal parasitic infection. These advances are reviewed, with emphasis on the treatment of cryptosporidiosis, microsporidiosis and disseminated strongyloidiasis. The emergence of drug resistance in giardiasis and mass treatment for geohelminths in areas of high endemicity are also discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 685-691 |
| Number of pages | 7 |
| Journal | Current Opinion in Infectious Diseases |
| Volume | 7 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Jan 1994 |